Evotec starts G-CON cleanroom POD installation in France

27-Jun-2023

Evotec has announced the installation of multiple cleanroom PODs in a Toulouse facility that will feature intensified, continuous bioprocessing operations housed inside the autonomous cleanroom PODs

Evotec starts G-CON cleanroom POD installation in France

Evotec has announced the arrival and start of installation of the cleanroom PODs at its J.POD biologics manufacturing facility located on Evotec’s Campus Curie in Toulouse, France.

Manufactured and delivered by G-CON, a global leader in off-site pre-fabricated cleanroom systems, the cleanroom PODs will be installed over the next few weeks. G-CON previously supplied the cleanroom PODs for the first J.POD facility at Just – Evotec Biologics’ site in Redmond, WA (US) in August 2021.

The PODs are one of the cornerstones for our continuous manufacturing platform enabling advanced and efficient biomanufacturing processes available to our partners for the benefit of patients worldwide.”

- Dr Linda Zuckerman, Executive VP of Global Head Biotherapeutics at Just – Evotec Biologics

The installation is an important step towards the completion of J.POD Toulouse, France, the second facility of its kind and the first one on European ground. The GMP biomanufacturing facility features intensified, continuous bioprocessing operations housed inside autonomous cleanroom PODs, and will provide low cost clinical and commercial manufacturing capacity for biologics.

Dr Linda Zuckerman, Executive VP of Global Head Biotherapeutics at Just – Evotec Biologics, said: “The installation of multiple cleanroom PODs by the G-CON team advances the construction of J.POD Toulouse, France (EU) significantly. The PODs are one of the cornerstones for our continuous manufacturing platform enabling advanced and efficient biomanufacturing processes available to our partners for the benefit of patients worldwide.”

Like this story? Subscribe to Cleanroom Technology magazine for incisive analysis of the latest news and developments in hi-tech industries manufacturing in controlled environments.

At its Redmond facility, Just – Evotec Biologics has been performing process development and GMP clinical manufacturing for partners including the US Department of Defense. In May, Just – Evotec Biologics announced a multi-year, long-term tech partnership with Sandoz for the immediate development and subsequent manufacturing of multiple biosimilars using Just – Evotec Biologics’ continuous manufacturing platform.

The combination of the PODs and cleanroom panels from G-CON Clean Solutions were seamlessly integrated by our teams for Just-Evotec Biologics, our first hybrid customer in Europe

- Dr Anne Jones, President and CEO of G-CON

“The combination of the PODs and cleanroom panels from G-CON Clean Solutions were seamlessly integrated by our teams for Just-Evotec Biologics, our first hybrid customer in Europe,” said Dr Anne Jones, President and CEO of G-CON. “We are thrilled to partner with Just Evotec Biologics, where our combined products are integral to supporting the build out of their leading-edge manufacturing platform.”

Sign up for your free email newsletter

The construction of J.POD Toulouse, France (EU) benefits from French government funding as part of the Investments for the Future Programme (programme d’investissements d’avenir in French) and is also supported economically by the Occitanie Region and Toulouse Métropole.

Companies